top of page
The Professional Network for Healthcare Experts
FDA accepts UroGen’s UGN-103 NDA for recurrent low-grade intermediate-risk bladder cancer
The submission seeks approval for a next-generation mitomycin formulation designed for intravesical treatment of recurrent low-grade intermediate-risk non-muscle invasive bladder cancer, building on the same drug-delivery platform as FDA-approved Zusduri.
nuaxia
16 hours ago2 min read
Lilly signs OmniAb ion channel discovery deal with up to $370 million in milestones
The global collaboration gives Lilly access to OmniAb’s specialist ion channel discovery and screening capabilities for an undisclosed therapeutic target and modality.
nuaxia
16 hours ago3 min read
Slate Medicines to merge with Fulcrum Therapeutics and raise $245 million to advance migraine pipeline
The reverse-merger transaction gives privately held Slate a Nasdaq listing and additional capital to advance its anti-PACAP migraine portfolio, led by clinical-stage monoclonal antibody SLTE-1009.
nuaxia
16 hours ago3 min read
Henlius and Sandoz expand biosimilars partnership with up to 10 global programmes
The collaboration combines Henlius’ biologics development, manufacturing and supply capabilities with Sandoz’s ex-China commercial infrastructure, initially covering three biosimilars and an option on a recombinant human hyaluronidase programme.
nuaxia
16 hours ago3 min read
IASO Bio acquires Singapore’s MediSix Therapeutics to expand global cell therapy platform
The acquisition adds MediSix’s proprietary T-cell engineering technologies and pipeline to IASO Bio’s integrated cell therapy capabilities while strengthening its presence in Singapore and international markets.
nuaxia
16 hours ago3 min read
FDA grants additional Fast Track designation to Phanes’ spevatamig for first-line metastatic pancreatic cancer
The designation expands spevatamig’s regulatory support to the broader first-line metastatic pancreatic ductal adenocarcinoma population as Phanes advances its CLDN18.2 × CD47 bispecific antibody through Phase II development.
nuaxia
16 hours ago3 min read
FDA approves Lerochol autoinjector and updates indication for monthly PCSK9 therapy
The new device gives adults with hypercholesterolaemia an additional self-administration option for once-monthly Lerochol, while updated prescribing information reflects evidence linking LDL-C reduction with lower cardiovascular event risk.
nuaxia
16 hours ago2 min read
Manitoba Physical Medicine Billings Reach C$631,534, 30% Above British Columbia
New physician payment data show physical medicine physicians generated substantially higher median gross billings in Manitoba than in British Columbia.
nuaxia
16 hours ago3 min read
British Columbia Dermatologist Billings Reach C$535,949, 7% Above Manitoba
New physician payment data show dermatologists generated higher median gross billings in British Columbia than in Manitoba.
nuaxia
17 hours ago3 min read
British Columbia Endocrinologist Billings Reach C$539,040, Provincial Analysis Finds
New physician payment data show endocrinologists generated median gross billings of more than C$539,000 in British Columbia.
nuaxia
17 hours ago3 min read
British Columbia Internal Medicine Billings Reach C$554,887, 55% Above Manitoba
New physician payment data show internal medicine physicians generated significantly higher median gross billings in British Columbia than in Manitoba.
nuaxia
17 hours ago3 min read
British Columbia Cardiac Surgeon Billings Reach C$559,313, Provincial Analysis Finds
New physician payment data show cardiac surgeons generated median gross billings of more than C$559,000 in British Columbia.
nuaxia
17 hours ago3 min read
British Columbia Obstetrician-Gynecologist Billings Reach C$567,094, 27% Above Manitoba
New physician payment data show obstetrician-gynaecologists generated significantly higher median gross billings in British Columbia than in Manitoba.
nuaxia
20 hours ago3 min read
British Columbia Neurosurgeon Billings Reach C$588,226, Provincial Analysis Finds
New physician payment data show neurosurgeons generated median gross billings of nearly C$590,000 in British Columbia.
nuaxia
20 hours ago3 min read
British Columbia Orthopedic Surgeon Billings Reach C$593,685, 7% Below Manitoba
New physician payment data show orthopedic surgeons generated higher median gross billings in Manitoba than in British Columbia.
nuaxia
20 hours ago3 min read
British Columbia Plastic Surgeon Billings Reach C$602,498, Provincial Analysis Finds
New physician payment data show plastic surgeons generated median gross billings of more than C$600,000 in British Columbia.
nuaxia
20 hours ago3 min read
British Columbia Anesthesiologist Billings Reach C$613,899, 48% Above Manitoba
New physician payment data show anesthesiologists generated significantly higher median gross billings in British Columbia than in Manitoba.
nuaxia
20 hours ago3 min read
British Columbia Critical Care Physician Billings Reach C$642,935, Provincial Analysis Finds
New physician payment data show critical care physicians generated median gross billings of more than C$640,000 in British Columbia.
nuaxia
21 hours ago3 min read
Skye Bioscience and Redx Pharma agree combination to create Fibrx Therapeutics with $125 million financing
The transaction creates a Nasdaq-listed fibrosis-focused company led by Redx’s management, with financing expected to fund the Phase II development of lead Crohn’s disease candidate RXC008 and provide cash runway into 2029.
nuaxia
2 days ago3 min read
Aizen Therapeutics signs AI peptide collaboration worth up to $100 million per target
The multi-program deal pairs Aizen’s DaX AI platform with an undisclosed San Diego biotechnology company to design oral peptide therapeutics against nominated immunology and neurology targets.
nuaxia
2 days ago3 min read
bottom of page